These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35753771)

  • 21. Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid.
    Soriano A; Ortega M; García S; Peñarroja G; Bové A; Marcos M; Martínez JC; Martínez JA; Mensa J
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2559-63. PubMed ID: 17470658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of augmented renal clearance on the lower incidence of linezolid-related hematological toxicity.
    Sánchez-Sanz B; Caro-Teller JM; Gonzalez-Barrios I; Rodríguez-Quesada PP; Hernández-Ramos JA; Ferrari-Piquero JM
    Farm Hosp; 2023; 47(5):190-195. PubMed ID: 37394377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes.
    Schneller-Pavelescu L; Vergara-de Caso E; Martorell A; Romaní J; Lázaro M; Vilarrasa E; Díaz-Ley B; Vázquez-Osorio I; Segura Palacios JM; Azaña JM; González-López MA; Cañueto J; Molina-Leyva A; Leiva-Salinas M; Navarro-Triviño FJ; Sánchez-Payá J; Pascual JC
    J Am Acad Dermatol; 2019 May; 80(5):1455-1457. PubMed ID: 30630028
    [No Abstract]   [Full Text] [Related]  

  • 24. Clindamycin-induced neutropenia following major head and neck surgery.
    Schmidt RS; Reiter ER
    Ear Nose Throat J; 2012 Sep; 91(9):E27-9. PubMed ID: 22996716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linezolid is safe on platelet count for AML patients during myelosuppression after consolidation chemotherapy.
    Zhou D; Shi T; Zhao S; Zhu J; Zhu L; Yang X; Xie W; Ye X
    J Clin Pharm Ther; 2020 Aug; 45(4):755-758. PubMed ID: 32403181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linezolid-related adverse effects in clinical practice in children.
    Bayram N; Düzgöl M; Kara A; Özdemir FM; Devrim İ
    Arch Argent Pediatr; 2017 Oct; 115(5):470-475. PubMed ID: 28895694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination.
    Kaya Kılıç E; Bulut C; Sönmezer MÇ; Ozel Ö; Ataman Hatipoğlu Ç; Tuncer Ertem G; Tülek N; Kınıklı S
    J Infect Dev Ctries; 2019 Oct; 13(10):886-891. PubMed ID: 32084018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelosuppression Rates with Administration of Nafcillin with and without Rifampin in Pediatric Patients.
    Kuriakose J; Kaplansky M; Sierra CM
    Pediatr Rep; 2022 Jun; 14(2):288-292. PubMed ID: 35736658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dose adjustment of linezolid due to interacction with rifampicin in infective endocarditis].
    Puplà Bartoll A; Bellés Medall MD; Pérez Catalán IE; Roig Martí C; Bodega Azuara J; Gil Candel M; Esteve López V; Ferrando Piqueres R
    Rev Esp Quimioter; 2023 Aug; 36(4):436-438. PubMed ID: 37116051
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of Incidence of Hyponatremia between Linezolid and Vancomycin by Propensity Score Matching Analysis.
    Tanaka R; Morinaga Y; Iwao M; Tatsuta R; Hashimoto T; Hiramatsu K; Itoh H
    Biol Pharm Bull; 2023; 46(10):1365-1370. PubMed ID: 37779038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.
    Nedved AN; DeFrates SR; Hladnik LM; Stockerl-Goldstein KE
    Pharmacotherapy; 2016 Oct; 36(10):1087-1094. PubMed ID: 27521990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.
    Bonnaire A; Vernet-Garnier V; Lebrun D; Bajolet O; Bonnet M; Hentzien M; Ohl X; Diallo S; Bani-Sadr F
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115225. PubMed ID: 33099073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination.
    Bernard A; Kermarrec G; Parize P; Caruba T; Bouvet A; Mainardi JL; Sabatier B; Nich C
    J Infect; 2015 Aug; 71(2):200-6. PubMed ID: 25936632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections.
    Nguyen S; Pasquet A; Legout L; Beltrand E; Dubreuil L; Migaud H; Yazdanpanah Y; Senneville E
    Clin Microbiol Infect; 2009 Dec; 15(12):1163-9. PubMed ID: 19438638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with linezolid for the treatment of orthopaedic implant infections.
    Morata L; Tornero E; Martínez-Pastor JC; García-Ramiro S; Mensa J; Soriano A
    J Antimicrob Chemother; 2014 Sep; 69 Suppl 1():i47-52. PubMed ID: 25135090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and clinical efficacy of linezolid in children: a systematic review and meta-analysis.
    Shi Y; Wu HL; Wu YH; Li S; Zhang LY; Xu SS; Huang HY; Zhang CH; Yu XB; Cai K; Zhang J; Huang LS
    World J Pediatr; 2023 Feb; 19(2):129-138. PubMed ID: 36562929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole.
    Dilley M; Geng B
    Clin Rev Allergy Immunol; 2022 Jun; 62(3):463-475. PubMed ID: 34910281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid.
    Zhang YM; Yu W; Zhou N; Li JZ; Xu LC; Xie ZY; Lu YF; Li LJ
    Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):287-92. PubMed ID: 26063030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.